1-5 of 5
Authors: Sandra Brosda
Journal Article
280. MULTI-OMIC FEATURES OF OESOPHAGEAL ADENOCARCINOMA PATIENTS PRE-TREATED WITH PREOPERATIVE NEOADJUVANT THERAPY Free
Diseases of the Esophagus, Volume 35, Issue Supplement_2, September 2022, doac051.280, https://doi.org/10.1093/dote/doac051.280
Published: 24 September 2022
Journal Article
204. THE TUMOUR IMMUNE MICROENVIRONMENT IN OESOPHAGEAL ADENOCARCINOMA HAS PROGNOSTIC SIGNIFICANCE Free
Diseases of the Esophagus, Volume 35, Issue Supplement_2, September 2022, doac051.204, https://doi.org/10.1093/dote/doac051.204
Published: 24 September 2022
Journal Article
RA10.05: CHEMORADIOTHERAPY IMPROVES LOCO-REGIONAL CONTROL AND DISEASE-FREE SURVIVAL OVER CHEMOTHERAPY IN OESOPHAGEAL ADENOCARCINOMA WITH SIGNET RING MORPHOLOGY Get access
Diseases of the Esophagus, Volume 31, Issue Supplement_1, September 2018, Page 43, https://doi.org/10.1093/dote/doy089.RA10.05
Published: 14 September 2018
Journal Article
PS02.207: NEUTROPHIL-LYMPHOCYTE RATIO HOLDS NO PROGNOSTIC VALUE FOR OESOPHAGEAL AND JUNCTIONAL ADENOCARCINOMA IN PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY Get access
Diseases of the Esophagus, Volume 31, Issue Supplement_1, September 2018, Page 181, https://doi.org/10.1093/dote/doy089.PS02.207
Published: 14 September 2018
Journal Article
PS01.176: OPEN VERSUS HYBRID VERSUS MINIMALLY INVASIVE ESOPHAGECTOMY FOR PATIENTS WITH ESOPHAGEAL CANCER: A PROPENSITY SCORE MATCHED ANALYSIS Get access
Diseases of the Esophagus, Volume 31, Issue Supplement_1, September 2018, Pages 99–100, https://doi.org/10.1093/dote/doy089.PS01.176
Published: 14 September 2018
